
1. antimicrob agents chemother. 2011 jan;55(1):382-4. doi: 10.1128/aac.01259-10.
epub 2010 nov 1.

cytomegalovirus ul97 mutations affecting cyclopropavir ganciclovir
susceptibility.

chou s(1), bowlin tl.

author information: 
(1)division infectious diseases, oregon health science university,
portland, or, usa. chous@ohsu.edu

among 7 common ul97 mutations encountered ganciclovir-resistant
clinical cytomegalovirus isolates, associated cyclopropavir cross-resistance 
varies insignificant (l595s) substantial (m460i h520q) determined 
by recombinant phenotyping. mutations m460i h520q preferentially
selected vitro cyclopropavir conferred 12- 20-fold increases in
50% effective concentration (ec(50)) values, m460v, c592g, a594v, c603w
conferred 3- 5-fold increases. uncommon mutations m460t c603r increased
cyclopropavir ec(50)s 8- 10-fold.

doi: 10.1128/aac.01259-10 
pmcid: pmc3019618
pmid: 21041510  [indexed medline]

